| human | Q5 |
| P6178 | Dimensions author ID | 01353217646.44 |
| P227 | GND ID | 132821745 |
| P213 | ISNI | 0000000022517925 |
| P496 | ORCID iD | 0000-0002-2708-2507 |
| P10013 | SNSF person ID | 559303 |
| P10861 | Springer Nature person ID | 01353217646.44 |
| P214 | VIAF ID | 20856149 |
| P10832 | WorldCat Entities ID | E39PBJw8Xc7MBHddwvpDhV97HC |
| P69 | educated at | University of Marburg | Q155354 |
| University of Kiel | Q156737 | ||
| P108 | employer | University of Marburg | Q155354 |
| University of Veterinary Medicine Hanover | Q1607255 | ||
| P734 | family name | Zimmer | Q203541 |
| Zimmer | Q203541 | ||
| Zimmer | Q203541 | ||
| P735 | given name | Gert | Q5553169 |
| Gert | Q5553169 | ||
| P106 | occupation | biologist | Q864503 |
| P21 | sex or gender | male | Q6581097 |
| Q54976877 | 1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features. |
| Q42931129 | A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus |
| Q43765093 | A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly(D,L-lactic-co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus |
| Q38337886 | A novel sorting signal for intracellular localization is present in the S protein of a porcine coronavirus but absent from severe acute respiratory syndrome-associated coronavirus. |
| Q39897024 | A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). |
| Q31037459 | A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon |
| Q41168571 | An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus |
| Q43844212 | Are intestinal mucins involved in the pathogenicity of transmissible gastroenteritis coronavirus? |
| Q24655046 | Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglycoproteins |
| Q24537641 | Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins. |
| Q34991399 | Biological and protective properties of immune sera directed to the influenza virus neuraminidase |
| Q112703649 | Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance |
| Q45416824 | Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves |
| Q39445369 | Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2. |
| Q39684652 | Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture |
| Q29041266 | Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium |
| Q43580948 | Comparison of the sialic acid binding activity of transmissible gastroenteritis coronavirus and E. coli K99. |
| Q33892350 | Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. |
| Q38793701 | Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses. |
| Q33881961 | Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease |
| Q39946464 | Formation of bovine viral diarrhea virus E1-E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains |
| Q45374488 | Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity |
| Q90969656 | Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion |
| Q112567074 | Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen |
| Q41323347 | Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line |
| Q57197569 | Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs |
| Q37423183 | Interferon-driven deletion of antiviral B cells at the onset of chronic infection. |
| Q97681414 | LY6E impairs coronavirus fusion and confers immune control of viral disease |
| Q61795278 | MHC class II proteins mediate cross-species entry of bat influenza viruses |
| Q92245998 | Macropinocytosis contributes to hantavirus entry into human airway epithelial cells |
| Q57197594 | Membrane Cofactor Protein (CD46) Is a Basolateral Protein That Is Not Endocytosed |
| Q45782521 | Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus |
| Q41093687 | Molecular characterization of gp40, a mucin-type glycoprotein from the apical plasma membrane of Madin-Darby canine kidney cells (type I) |
| Q39602758 | N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus |
| Q57093905 | Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype |
| Q40041564 | Novel insights into bat influenza A viruses |
| Q41927480 | Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein |
| Q38436945 | Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies |
| Q57490101 | Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells |
| Q40797384 | Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences |
| Q42219562 | Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses |
| Q41810186 | Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism |
| Q37281773 | Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles. |
| Q97563612 | Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes |
| Q38741327 | Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. |
| Q43940795 | Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies |
| Q39742113 | Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection |
| Q45777150 | Surface glycoprotein of influenza C virus: inactivation and restoration of the acetylesterase activity on nitrocellulose |
| Q41138797 | The cell receptor level is reduced during persistent infection with influenza C virus |
| Q40021220 | The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis |
| Q34515872 | The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. |
| Q40563460 | The surface glycoprotein E2 of bovine viral diarrhoea virus contains an intracellular localization signal |
| Q35746584 | Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease. |
| Q45857926 | Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity |
| Q45481602 | Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes |
| Q34770423 | Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus. |
| Q39683224 | Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells |
| Q39142927 | Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection |
| Q44354620 | Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus |
| Q41162632 | Virus entry into a polarized epithelial cell line (MDCK): similarities and dissimilarities between influenza C virus and bovine coronavirus |
| Q45324179 | Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs |
| Q38573583 | Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs |
| Q112287774 | Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants |
Search more.